Larvol Delta - 89bio-Announces-US-FDA-has-Granted-Breakthrough-Therapy-Designation-for-Pegozafermin-in-Nonalcoholic-Steatohepatitis-NASH

pegozafermin (BIO89-100) - 89Bio

https://www.globenewswire.com/news-release/2023/09/21/2747202/0/en/89bio-Announces-U-S-FDA-has-Granted-Breakthrough-Therapy-Designation-for-Pegozafermin-in-Nonalcoholic-Steatohepatitis-NASH.html

Sep 21, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next